Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaaw7736. doi: 10.1126/scitranslmed.aaw7736.

PMID:
31434756
2.

Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.

Lobatto ME, Binderup T, Robson PM, Giesen LFP, Calcagno C, Witjes J, Fay F, Baxter S, Wessel CH, Eldib M, Bini J, Carlin SD, Stroes ESG, Storm G, Kjaer A, Lewis JS, Reiner T, Fayad ZA, Mulder WJM, Pérez-Medina C.

Bioconjug Chem. 2019 Jun 7. doi: 10.1021/acs.bioconjchem.9b00256. [Epub ahead of print]

PMID:
31095372
3.

A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.

Piñero F, Vazquez M, Baré P, Rohr C, Mendizabal M, Sciara M, Alonso C, Fay F, Silva M.

Ann Hepatol. 2019 May - Jun;18(3):480-487. doi: 10.1016/j.aohep.2018.10.003. Epub 2019 Apr 15.

4.

Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 Aug;2(8):623. doi: 10.1038/s41551-018-0281-3.

PMID:
31015637
5.

Non-Leachable Hydrophilic Additives for Amphiphilic Coatings.

Gillet G, Azemar F, Faÿ F, Réhel K, Linossier I.

Polymers (Basel). 2018 Apr 16;10(4). pii: E445. doi: 10.3390/polym10040445.

6.

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 May;2(5):279-292. doi: 10.1038/s41551-018-0221-2. Epub 2018 Apr 16. Erratum in: Nat Biomed Eng. 2018 Aug;2(8):623.

7.

Additives for Efficient Biodegradable Antifouling Paints.

Faÿ F, Gouessan M, Linossier I, Réhel K.

Int J Mol Sci. 2019 Jan 16;20(2). pii: E361. doi: 10.3390/ijms20020361.

8.

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.

Braza MS, van Leent MMT, Lameijer M, Sanchez-Gaytan BL, Arts RJW, Pérez-Medina C, Conde P, Garcia MR, Gonzalez-Perez M, Brahmachary M, Fay F, Kluza E, Kossatz S, Dress RJ, Salem F, Rialdi A, Reiner T, Boros P, Strijkers GJ, Calcagno CC, Ginhoux F, Marazzi I, Lutgens E, Nicolaes GAF, Weber C, Swirski FK, Nahrendorf M, Fisher EA, Duivenvoorden R, Fayad ZA, Netea MG, Mulder WJM, Ochando J.

Immunity. 2018 Nov 20;49(5):819-828.e6. doi: 10.1016/j.immuni.2018.09.008. Epub 2018 Nov 6.

9.

Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.

Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, Tang J, Alaarg A, Zhao Y, Ishino S, Palmisano A, Boeykens G, Meerwaldt AE, Sanchez-Gaytan BL, Baxter S, Zendman L, Lobatto ME, Karakatsanis NA, Robson PM, Broisat A, Raes G, Lewis JS, Tsimikas S, Reiner T, Fayad ZA, Devoogdt N, Mulder WJM, Pérez-Medina C.

JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026. doi: 10.1016/j.jcmg.2018.07.027. Epub 2018 Oct 17.

10.

Anti-Bacterial Adhesion Activity of Tropical Microalgae Extracts.

Zea-Obando C, Tunin-Ley A, Turquet J, Culioli G, Briand JF, Bazire A, Réhel K, Faÿ F, Linossier I.

Molecules. 2018 Aug 29;23(9). pii: E2180. doi: 10.3390/molecules23092180.

11.

Exome-first approach identified novel INDELs and gene deletions in Mowat-Wilson Syndrome patients.

Gosso MF, Rohr C, Brun B, Mejico G, Madeira F, Fay F, Klurfan M, Vazquez M.

Hum Genome Var. 2018 Aug 1;5:21. doi: 10.1038/s41439-018-0021-y. eCollection 2018.

12.

Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.

Senders ML, Lobatto ME, Soler R, Lairez O, Pérez-Medina C, Calcagno C, Fayad ZA, Mulder WJM, Fay F.

Methods Mol Biol. 2018;1816:385-400. doi: 10.1007/978-1-4939-8597-5_30.

PMID:
29987836
13.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

14.

PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Senders ML, Que X, Cho YS, Yeang C, Groenen H, Fay F, Calcagno C, Meerwaldt AE, Green S, Miu P, Lobatto ME, Reiner T, Fayad ZA, Witztum JL, Mulder WJM, Pérez-Medina C, Tsimikas S.

J Am Coll Cardiol. 2018 Jan 23;71(3):321-335. doi: 10.1016/j.jacc.2017.11.036.

15.

Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance.

Braza MS, Conde P, Garcia M, Cortegano I, Brahmachary M, Pothula V, Fay F, Boros P, Werner SA, Ginhoux F, Mulder WJM, Ochando J.

Am J Transplant. 2018 May;18(5):1247-1255. doi: 10.1111/ajt.14645. Epub 2018 Feb 7.

16.

Sponge-Inspired Dibromohemibastadin Prevents and Disrupts Bacterial Biofilms without Toxicity.

Le Norcy T, Niemann H, Proksch P, Tait K, Linossier I, Réhel K, Hellio C, Faÿ F.

Mar Drugs. 2017 Jul 12;15(7). pii: E222. doi: 10.3390/md15070222.

17.

Anti-Biofilm Effect of Biodegradable Coatings Based on Hemibastadin Derivative in Marine Environment.

Norcy TL, Niemann H, Proksch P, Linossier I, Vallée-Réhel K, Hellio C, Faÿ F.

Int J Mol Sci. 2017 Jul 13;18(7). pii: E1520. doi: 10.3390/ijms18071520.

18.

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.

Alaarg A, Senders ML, Varela-Moreira A, Pérez-Medina C, Zhao Y, Tang J, Fay F, Reiner T, Fayad ZA, Hennink WE, Metselaar JM, Mulder WJM, Storm G.

J Control Release. 2017 Sep 28;262:47-57. doi: 10.1016/j.jconrel.2017.07.013. Epub 2017 Jul 9.

19.

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.

Beldman TJ, Senders ML, Alaarg A, Pérez-Medina C, Tang J, Zhao Y, Fay F, Deichmöller J, Born B, Desclos E, van der Wel NN, Hoebe RA, Kohen F, Kartvelishvily E, Neeman M, Reiner T, Calcagno C, Fayad ZA, de Winther MPJ, Lutgens E, Mulder WJM, Kluza E.

ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.

20.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Fay F, Hansen L, Hectors SJCG, Sanchez-Gaytan BL, Zhao Y, Tang J, Munitz J, Alaarg A, Braza MS, Gianella A, Aaronson SA, Reiner T, Kjems J, Langer R, Hoeben FJM, Janssen HM, Calcagno C, Strijkers GJ, Fayad ZA, Pérez-Medina C, Mulder WJM.

Bioconjug Chem. 2017 May 17;28(5):1413-1421. doi: 10.1021/acs.bioconjchem.7b00086. Epub 2017 May 5.

21.

Influence of Biodegradable Polymer Properties on Antifouling Paints Activity.

Loriot M, Linossier I, Vallée-Réhel K, Faÿ F.

Polymers (Basel). 2017 Jan 25;9(2). pii: E36. doi: 10.3390/polym9020036.

22.

Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.

Sanchez-Gaytan BL, Fay F, Hak S, Alaarg A, Fayad ZA, Pérez-Medina C, Mulder WJ, Zhao Y.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2923-2926. doi: 10.1002/anie.201611288. Epub 2017 Jan 23.

23.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Keliher EJ, Ye YX, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, Groenen H, Fay F, Perez-Medina C, Calcagno C, Carlucci G, Reiner T, Sun Y, Courties G, Iwamoto Y, Kim HY, Wang C, Chen JW, Swirski FK, Wey HY, Hooker J, Fayad ZA, Mulder WJ, Weissleder R, Nahrendorf M.

Nat Commun. 2017 Jan 16;8:14064. doi: 10.1038/ncomms14064.

24.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R, Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJ.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740. Epub 2016 Oct 17.

25.

Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids.

Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad ZA, Mulder WJ.

ACS Omega. 2016 Sep 30;1(3):470-475. Epub 2016 Sep 26.

26.

Rapid identification of osmolytes in tropical microalgae and cyanobacteria by (1)H HR-MAS NMR spectroscopy.

Zea Obando C, Linossier I, Kervarec N, Zubia M, Turquet J, Faÿ F, Rehel K.

Talanta. 2016 Jun 1;153:372-80. doi: 10.1016/j.talanta.2016.02.024. Epub 2016 Feb 12.

PMID:
27130130
27.

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ.

Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221.

28.

Human Microbiota of the Argentine Population- A Pilot Study.

Carbonetto B, Fabbro MC, Sciara M, Seravalle A, Méjico G, Revale S, Romero MS, Brun B, Fay M, Fay F, Vazquez MP.

Front Microbiol. 2016 Feb 1;7:51. doi: 10.3389/fmicb.2016.00051. eCollection 2016.

29.

Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.

Spence S, Greene MK, Fay F, Hams E, Saunders SP, Hamid U, Fitzgerald M, Beck J, Bains BK, Smyth P, Themistou E, Small DM, Schmid D, O'Kane CM, Fitzgerald DC, Abdelghany SM, Johnston JA, Fallon PG, Burrows JF, McAuley DF, Kissenpfennig A, Scott CJ.

Sci Transl Med. 2015 Sep 2;7(303):303ra140. doi: 10.1126/scitranslmed.aab3459.

PMID:
26333936
30.

Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Tang J, Lobatto ME, Hassing L, van der Staay S, van Rijs SM, Calcagno C, Braza MS, Baxter S, Fay F, Sanchez-Gaytan BL, Duivenvoorden R, Sager H, Astudillo YM, Leong W, Ramachandran S, Storm G, Pérez-Medina C, Reiner T, Cormode DP, Strijkers GJ, Stroes ES, Swirski FK, Nahrendorf M, Fisher EA, Fayad ZA, Mulder WJ.

Sci Adv. 2015 Apr;1(3). pii: e1400223.

31.

Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.

Moragas M, Belloso WH, Baquedano MS, Gutierrez MI, Bissio E, Larriba JM, Fay F, Aulicino P, Gurevich JM, Yaunguzian MF, Maldonado AC, Falistocco C, Sen L, Mangano A.

Tissue Antigens. 2015 Jul;86(1):28-31. doi: 10.1111/tan.12575. Epub 2015 Apr 29.

PMID:
25922880
32.

HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.

Sanchez-Gaytan BL, Fay F, Lobatto ME, Tang J, Ouimet M, Kim Y, van der Staay SE, van Rijs SM, Priem B, Zhang L, Fisher EA, Moore KJ, Langer R, Fayad ZA, Mulder WJ.

Bioconjug Chem. 2015 Mar 18;26(3):443-51. doi: 10.1021/bc500517k. Epub 2015 Feb 13.

33.

Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Lobatto ME, Calcagno C, Millon A, Senders ML, Fay F, Robson PM, Ramachandran S, Binderup T, Paridaans MP, Sensarn S, Rogalla S, Gordon RE, Cardoso L, Storm G, Metselaar JM, Contag CH, Stroes ES, Fayad ZA, Mulder WJ.

ACS Nano. 2015 Feb 24;9(2):1837-47. doi: 10.1021/nn506750r. Epub 2015 Jan 28.

34.

Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity.

Schmid D, Jarvis GE, Fay F, Small DM, Greene MK, Majkut J, Spence S, McLaughlin KM, McCloskey KD, Johnston PG, Kissenpfennig A, Longley DB, Scott CJ.

Cell Death Dis. 2014 Oct 9;5:e1454. doi: 10.1038/cddis.2014.413.

35.

Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine.

Schmid D, Fay F, Small DM, Jaworski J, Riley JS, Tegazzini D, Fenning C, Jones DS, Johnston PG, Longley DB, Scott CJ.

Mol Ther. 2014 Dec;22(12):2083-92. doi: 10.1038/mt.2014.137. Epub 2014 Jul 23.

36.

Bacteria and diatom resistance of silicones modified with PEO-silane amphiphiles.

Hawkins ML, Faÿ F, Réhel K, Linossier I, Grunlan MA.

Biofouling. 2014 Feb;30(2):247-58. doi: 10.1080/08927014.2013.862235.

PMID:
24447301
37.

Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.

Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, Fay F, Senders ML, Calcagno C, Becraft J, Tun Saung M, Gordon RE, Stroes ES, Ma M, Farokhzad OC, Fayad ZA, Mulder WJ, Langer R.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1078-83. doi: 10.1073/pnas.1322725111. Epub 2014 Jan 6.

38.

Alteration of bacterial adhesion induced by the substrate stiffness.

Guégan C, Garderes J, Le Pennec G, Gaillard F, Fay F, Linossier I, Herry JM, Fontaine MN, Réhel KV.

Colloids Surf B Biointerfaces. 2014 Feb 1;114:193-200. doi: 10.1016/j.colsurfb.2013.10.010. Epub 2013 Oct 14.

PMID:
24189194
39.

Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing mice.

Zhao Y, van Rooy I, Hak S, Fay F, Tang J, Davies Cde L, Skobe M, Fisher EA, Radu A, Fayad ZA, de Mello Donegá C, Meijerink A, Mulder WJ.

ACS Nano. 2013 Nov 26;7(11):10362-70. doi: 10.1021/nn404782p. Epub 2013 Oct 24.

40.

Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Allijn IE, Leong W, Tang J, Gianella A, Mieszawska AJ, Fay F, Ma G, Russell S, Callo CB, Gordon RE, Korkmaz E, Post JA, Zhao Y, Gerritsen HC, Thran A, Proksa R, Daerr H, Storm G, Fuster V, Fisher EA, Fayad ZA, Mulder WJ, Cormode DP.

ACS Nano. 2013 Nov 26;7(11):9761-70. doi: 10.1021/nn403258w. Epub 2013 Oct 17.

41.

Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.

Kim Y, Fay F, Cormode DP, Sanchez-Gaytan BL, Tang J, Hennessy EJ, Ma M, Moore K, Farokhzad OC, Fisher EA, Mulder WJ, Langer R, Fayad ZA.

ACS Nano. 2013 Nov 26;7(11):9975-83. doi: 10.1021/nn4039063. Epub 2013 Oct 3.

42.

Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.

Fay F, Sanchez-Gaytan BL, Cormode DP, Skajaa T, Fisher EA, Fayad ZA, Mulder WJ.

Curr Cardiovasc Imaging Rep. 2013 Feb 1;6(1):45-54.

43.

Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.

Zaric M, Lyubomska O, Touzelet O, Poux C, Al-Zahrani S, Fay F, Wallace L, Terhorst D, Malissen B, Henri S, Power UF, Scott CJ, Donnelly RF, Kissenpfennig A.

ACS Nano. 2013 Mar 26;7(3):2042-55. doi: 10.1021/nn304235j. Epub 2013 Feb 15.

44.

Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles.

Abdelghany SM, Schmid D, Deacon J, Jaworski J, Fay F, McLaughlin KM, Gormley JA, Burrows JF, Longley DB, Donnelly RF, Scott CJ.

Biomacromolecules. 2013 Feb 11;14(2):302-10. doi: 10.1021/bm301858a. Epub 2013 Jan 31.

45.

[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].

Silva MO, Ridruejo E, Galdame O, Bessone F, Colombato L, Daruich J, Fainboim H, Fassio E, Fay F, Frider B, Gadano A, Galoppo MC, González J, Tanno H, Terg R, Villamil F; Comisión de Expertos en Hepatitis Virales de la Asociaci6n Argentina para el Estudio de las Enfermedades; del Hígado.

Acta Gastroenterol Latinoam. 2012 Sep;42(3):234-49. Spanish. No abstract available.

PMID:
23214356
46.

Joint-action of antifouling substances in copper-free paints.

Faÿ F, Carteau D, Linossier I, Delbury M, Vallée-Réhel K.

Colloids Surf B Biointerfaces. 2013 Feb 1;102:569-77. doi: 10.1016/j.colsurfb.2012.08.055. Epub 2012 Sep 7.

PMID:
23104027
47.

 Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.

Reggiardo MV, Fay F, Tanno M, García-Camacho G, Bottaso O, Ferretti S, Godoy A, Guerrita C, Paez M, Tanno F, Ruffinengo O, Benetti S, García Borrás SE, Rossi MC, Vorobioff J, Bessone F, Tanno H.

Ann Hepatol. 2012 Sep-Oct;11(5):658-66.

48.

 Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative.

Bessone F, Hernandez N, Dávalos M, Paraná R, Schinoni MI, Lizarzabal M, Kershenobich D, Loaeza A, Arrese M, Chirino RA, Méndez-Sánchez N, Fay F, Bruguera M, Stephens C, Lucena MI, Andrade RJ.

Ann Hepatol. 2012 Jul-Aug;11(4):544-9. No abstract available.

49.

Dynamic approaches of mixed species biofilm formation using modern technologies.

Doiron K, Linossier I, Fay F, Yong J, Abd Wahid E, Hadjiev D, Bourgougnon N.

Mar Environ Res. 2012 Jul;78:40-7. doi: 10.1016/j.marenvres.2012.04.001. Epub 2012 Apr 14.

PMID:
22542567
50.

Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes.

Sede M, Ojeda D, Cassino L, Westergaard G, Vazquez M, Benetti S, Fay F, Tanno H, Quarleri J.

Antiviral Res. 2012 May;94(2):184-7. doi: 10.1016/j.antiviral.2012.03.003. Epub 2012 Mar 20.

PMID:
22453135

Supplemental Content

Support Center